Picture of Chimerix logo

CMRX — Chimerix News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Chimerix Inc reports results for the quarter ended in December - Earnings Summary

* Chimerix Inc  CMRX.OQ  reported a quarterly adjusted loss
of 20
cents​​ per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -24
cents.  The mean expectation of seven analysts for the quarter
was for a loss of 24 cents per share. Wall Street expected
results to range from -27 cents to -18 cents per share.
    * Revenue fell 99.5% to $4.00 thousand from a year ago;
analysts
expected $60.00 thousand. 
    * Chimerix Inc's reported EPS for the quarter was a loss
of 20
cents​.
    * The company reported a quarterly loss of $18.16 million.
    * Chimerix Inc shares had risen by 28.8% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Chimerix
Inc is
$7.00 

This summary was machine generated from LSEG data February 29 at
02:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.24          -0.20          Beat
 Sep. 30 2023      -0.23          -0.27          Missed
 Jun. 30 2023      -0.24          -0.21          Beat
 Mar. 31 2023      -0.25          -0.24          Beat

Recent news on Chimerix

See all news